SCHEMBL17614109

SCHEMBL17614109

Cc1cc(C)c(C)c([SH](C)(=O)Nc2cc(C(CC(=O)OC(C)(C)C)c3ccccc3)cc3ccccc23)c1C

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.33
▸ BACE1 P56817 1/20 0.32
▸ CDC25B P30305 1/20 0.31
▸ CTSS P25774 1/20 0.31
▸ CTSK P43235 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ CASR P41180 1/20 0.30
▸ GABRB1 P18505 1/20 0.30
▸ GABRB2 P47870 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ TACR1 P25103 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17614142 0.84 CTSS (0.31) BRD4CTSSCTSKCASRLMNA
SCHEMBL17599545 0.81 ALDH1A1 (0.47) ALDH1A1MAPTMEN1LMNAKMT2A
SCHEMBL17614108 0.75 KMT2A (0.34) CDC25BMEN1LMNACYP3A4CYP2C9
SCHEMBL17613771 0.70 ACP1 (0.39) ALDH1A1MAPTMEN1KMT2A
SCHEMBL17599526 0.67 ALDH1A1 (0.53) BRD4ALDH1A1MAPTMEN1LMNA
SCHEMBL9413687 0.67 CACNA2D1 (0.47) BRD4CTSSCTSKALDH1A1MAPT
SCHEMBL17599546 0.67 MEN1 (0.45) ALDH1A1MAPTMEN1LMNAKMT2A
SCHEMBL9413681 0.66 BRD4 (0.44) BRD4CTSSCTSKALDH1A1MAPT
SCHEMBL27647476 0.65 CYP2C9 (0.39) BACE1CTSSCTSKALDH1A1CYP2C9
SCHEMBL2886224 0.64 GPBAR1 (0.49) ALDH1A1MAPTMEN1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback